TPST: Tempest Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
20 institutions reported holding $1.14M of Tempest Therapeutics, Inc. on Form 13F (21 the quarter before). 4 opened a new position and 5 sold out. Shares held by institutions: +98%.
| Largest holders | Shares | Value |
|---|---|---|
| SABBY MANAGEMENT, LLC | 511,286 | $568K |
| VANGUARD CAPITAL MANAGEMENT LLC | 233,888 | $260K |
| GEODE CAPITAL MANAGEMENT, LLC | 86,625 | $96K |
| VANGUARD FIDUCIARY TRUST CO | 68,908 | $76K |
| BlackRock, Inc. | 39,068 | $43K |
| Squarepoint Ops LLC | 30,900 | $34K |
| NORTHERN TRUST CORP | 20,136 | $22K |
| CITADEL ADVISORS LLC | 19,820 | $22K |
| UBS Group AG | 5,636 | $6K |
| Tower Research Capital LLC (TRC) | 3,922 | $4K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.